Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 16 | 2024 | 2554 | 1.960 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 3 | 2019 | 495 | 0.720 |
Why?
|
Paraproteinemias | 1 | 2022 | 245 | 0.700 |
Why?
|
Receptors, Transforming Growth Factor beta | 2 | 2019 | 310 | 0.670 |
Why?
|
Ouabain | 2 | 2016 | 264 | 0.660 |
Why?
|
Myofibroblasts | 4 | 2019 | 218 | 0.630 |
Why?
|
Cardiac Glycosides | 1 | 2016 | 30 | 0.550 |
Why?
|
Digoxin | 1 | 2016 | 249 | 0.500 |
Why?
|
Prodrugs | 1 | 2015 | 266 | 0.450 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2015 | 616 | 0.400 |
Why?
|
Multiple Myeloma | 3 | 2023 | 5076 | 0.370 |
Why?
|
Fibroblasts | 3 | 2019 | 4160 | 0.370 |
Why?
|
Transforming Growth Factor beta | 3 | 2019 | 2005 | 0.370 |
Why?
|
Venous Thromboembolism | 4 | 2024 | 1770 | 0.370 |
Why?
|
Drug Discovery | 2 | 2016 | 1060 | 0.360 |
Why?
|
Plasma Cells | 3 | 2023 | 596 | 0.340 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3531 | 0.300 |
Why?
|
Neoplasms | 9 | 2024 | 21976 | 0.280 |
Why?
|
Lung | 4 | 2019 | 9990 | 0.240 |
Why?
|
Learning | 1 | 2024 | 1727 | 0.240 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 3 | 2016 | 495 | 0.230 |
Why?
|
Algorithms | 3 | 2024 | 13984 | 0.220 |
Why?
|
Cell Differentiation | 3 | 2019 | 11553 | 0.200 |
Why?
|
Frail Elderly | 2 | 2023 | 696 | 0.200 |
Why?
|
Pulmonary Fibrosis | 3 | 2019 | 530 | 0.200 |
Why?
|
Disulfiram | 1 | 2021 | 58 | 0.200 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1856 | 0.200 |
Why?
|
Technology | 1 | 2024 | 307 | 0.200 |
Why?
|
United States Department of Veterans Affairs | 2 | 2022 | 891 | 0.190 |
Why?
|
Patient Identification Systems | 1 | 2020 | 79 | 0.180 |
Why?
|
Vaccination | 6 | 2023 | 3354 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2021 | 317 | 0.180 |
Why?
|
Tannins | 1 | 2019 | 17 | 0.180 |
Why?
|
Workflow | 2 | 2024 | 852 | 0.170 |
Why?
|
HIV-1 | 3 | 2016 | 6981 | 0.160 |
Why?
|
Melanoma | 3 | 2022 | 5547 | 0.160 |
Why?
|
Humans | 49 | 2024 | 752741 | 0.160 |
Why?
|
Antiviral Agents | 5 | 2024 | 3012 | 0.160 |
Why?
|
Natural Language Processing | 2 | 2023 | 1059 | 0.160 |
Why?
|
Veterans Health | 2 | 2024 | 218 | 0.150 |
Why?
|
Delivery of Health Care | 4 | 2023 | 5380 | 0.150 |
Why?
|
Retrospective Studies | 15 | 2024 | 78758 | 0.150 |
Why?
|
United States | 12 | 2024 | 70772 | 0.140 |
Why?
|
Interleukin-10 | 1 | 2022 | 1205 | 0.140 |
Why?
|
Antifibrinolytic Agents | 1 | 2019 | 259 | 0.140 |
Why?
|
Venous Thrombosis | 2 | 2024 | 1295 | 0.140 |
Why?
|
Integrase Inhibitors | 1 | 2016 | 12 | 0.140 |
Why?
|
Cardiotonic Agents | 2 | 2019 | 531 | 0.140 |
Why?
|
Virus Diseases | 1 | 2022 | 722 | 0.130 |
Why?
|
Geriatric Assessment | 1 | 2023 | 1390 | 0.130 |
Why?
|
Ribonuclease H | 1 | 2015 | 47 | 0.130 |
Why?
|
Psoriasis | 1 | 2023 | 913 | 0.130 |
Why?
|
Pandemics | 4 | 2023 | 8607 | 0.130 |
Why?
|
HIV Reverse Transcriptase | 1 | 2016 | 213 | 0.130 |
Why?
|
Lymphoma | 1 | 2024 | 1892 | 0.120 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2015 | 300 | 0.120 |
Why?
|
HIV Integrase | 1 | 2016 | 120 | 0.120 |
Why?
|
Noscapine | 1 | 2014 | 1 | 0.120 |
Why?
|
Antitussive Agents | 1 | 2014 | 16 | 0.120 |
Why?
|
RNA, Viral | 1 | 2022 | 2908 | 0.120 |
Why?
|
Receptors, Prostaglandin E | 1 | 2014 | 56 | 0.120 |
Why?
|
Fibrosis | 2 | 2019 | 2028 | 0.120 |
Why?
|
Occupational Health | 1 | 2020 | 807 | 0.120 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13263 | 0.120 |
Why?
|
Cyclooxygenase 2 | 1 | 2016 | 612 | 0.110 |
Why?
|
Adrenomedullin | 1 | 2013 | 87 | 0.110 |
Why?
|
Pulmonary Embolism | 2 | 2024 | 2481 | 0.110 |
Why?
|
Small Molecule Libraries | 2 | 2016 | 722 | 0.110 |
Why?
|
Indoles | 1 | 2021 | 1839 | 0.110 |
Why?
|
Cells, Cultured | 3 | 2019 | 19270 | 0.110 |
Why?
|
Knowledge | 1 | 2024 | 183 | 0.100 |
Why?
|
Cohort Studies | 7 | 2023 | 40939 | 0.100 |
Why?
|
Skin Neoplasms | 2 | 2021 | 5751 | 0.100 |
Why?
|
Dexamethasone | 3 | 2023 | 1945 | 0.100 |
Why?
|
Influenza Vaccines | 1 | 2018 | 762 | 0.100 |
Why?
|
DNA Primers | 1 | 2015 | 2880 | 0.090 |
Why?
|
Dendrimers | 1 | 2010 | 71 | 0.090 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2016 | 467 | 0.090 |
Why?
|
Software | 2 | 2023 | 4460 | 0.090 |
Why?
|
Cell Death | 1 | 2015 | 1698 | 0.090 |
Why?
|
Risk Factors | 8 | 2024 | 73094 | 0.090 |
Why?
|
Enzyme Activation | 1 | 2016 | 3674 | 0.090 |
Why?
|
Electronic Health Records | 2 | 2023 | 4579 | 0.090 |
Why?
|
Down-Regulation | 1 | 2016 | 2987 | 0.080 |
Why?
|
Hospitals, Veterans | 2 | 2022 | 409 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2446 | 0.080 |
Why?
|
Thrombosis | 1 | 2023 | 3035 | 0.080 |
Why?
|
Air Pollution | 1 | 2022 | 2326 | 0.080 |
Why?
|
Aged | 11 | 2024 | 165629 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4311 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3766 | 0.080 |
Why?
|
Ambulatory Care Facilities | 1 | 2024 | 936 | 0.070 |
Why?
|
Medical Records | 2 | 2023 | 1412 | 0.070 |
Why?
|
Virus Replication | 1 | 2015 | 2538 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3246 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3111 | 0.070 |
Why?
|
Signal Transduction | 3 | 2019 | 23512 | 0.070 |
Why?
|
Prognosis | 2 | 2023 | 29264 | 0.070 |
Why?
|
Phosphorylation | 1 | 2016 | 8414 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 3753 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7708 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18460 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5284 | 0.060 |
Why?
|
Gene Expression | 1 | 2016 | 7771 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2021 | 3627 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3136 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3246 | 0.050 |
Why?
|
Bleomycin | 2 | 2014 | 513 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13678 | 0.050 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2021 | 65 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2024 | 11211 | 0.050 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2021 | 105 | 0.050 |
Why?
|
Incidence | 3 | 2024 | 21146 | 0.050 |
Why?
|
Oxygen | 2 | 2022 | 4208 | 0.050 |
Why?
|
Eligibility Determination | 1 | 2024 | 409 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2016 | 4285 | 0.040 |
Why?
|
RNA-Binding Protein EWS | 1 | 2021 | 216 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2022 | 695 | 0.040 |
Why?
|
Male | 11 | 2024 | 354311 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 635 | 0.040 |
Why?
|
Systems Integration | 1 | 2020 | 441 | 0.040 |
Why?
|
Hospitalization | 3 | 2022 | 10422 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58361 | 0.040 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.040 |
Why?
|
Attitude | 1 | 2023 | 783 | 0.040 |
Why?
|
SEER Program | 1 | 2022 | 1510 | 0.040 |
Why?
|
Hemoglobins | 1 | 2023 | 1537 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2021 | 571 | 0.040 |
Why?
|
Adult | 6 | 2024 | 216658 | 0.040 |
Why?
|
Registries | 2 | 2022 | 8216 | 0.030 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2018 | 554 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1087 | 0.030 |
Why?
|
Immunoglobulin A | 1 | 2018 | 996 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1917 | 0.030 |
Why?
|
Mice | 6 | 2021 | 81766 | 0.030 |
Why?
|
Middle Aged | 6 | 2024 | 216054 | 0.030 |
Why?
|
Female | 9 | 2024 | 385090 | 0.030 |
Why?
|
Hydroxyproline | 1 | 2014 | 117 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1812 | 0.030 |
Why?
|
Receptor Activity-Modifying Protein 2 | 1 | 2013 | 4 | 0.030 |
Why?
|
Calcitonin Receptor-Like Protein | 1 | 2013 | 8 | 0.030 |
Why?
|
Iloprost | 1 | 2013 | 28 | 0.030 |
Why?
|
Steroids | 1 | 2019 | 940 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1579 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 646 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3198 | 0.030 |
Why?
|
Animals | 7 | 2021 | 169600 | 0.030 |
Why?
|
Risk Assessment | 2 | 2024 | 23554 | 0.030 |
Why?
|
Medical Oncology | 1 | 2024 | 2298 | 0.030 |
Why?
|
Luciferases | 1 | 2014 | 732 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2259 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 2015 | 943 | 0.020 |
Why?
|
Potassium | 1 | 2015 | 1329 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16789 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1785 | 0.020 |
Why?
|
Alcoholism | 1 | 2021 | 1936 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4420 | 0.020 |
Why?
|
Particulate Matter | 1 | 2022 | 2574 | 0.020 |
Why?
|
Drug Stability | 1 | 2010 | 292 | 0.020 |
Why?
|
Sodium | 1 | 2015 | 1625 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2730 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2010 | 560 | 0.020 |
Why?
|
Herpesvirus 2, Human | 1 | 2010 | 190 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2013 | 1480 | 0.020 |
Why?
|
Cell Line | 2 | 2015 | 16004 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2019 | 22009 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7538 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3837 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9743 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2010 | 499 | 0.020 |
Why?
|
Microtubules | 1 | 2014 | 1092 | 0.020 |
Why?
|
Astrocytes | 1 | 2015 | 1301 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9348 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 53863 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2018 | 3194 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7400 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12423 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10450 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2018 | 4575 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2022 | 13011 | 0.020 |
Why?
|
Phenotype | 1 | 2024 | 16484 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 21904 | 0.020 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2010 | 961 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4526 | 0.020 |
Why?
|
Lysine | 1 | 2010 | 1005 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2010 | 729 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5743 | 0.020 |
Why?
|
Actins | 1 | 2013 | 2114 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10508 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2010 | 3120 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2015 | 8285 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15404 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13364 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6670 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15657 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2021 | 9664 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2015 | 3757 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11626 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10751 | 0.010 |
Why?
|
Transcription Factors | 1 | 2021 | 12165 | 0.010 |
Why?
|
Models, Molecular | 1 | 2010 | 5460 | 0.010 |
Why?
|
DNA | 1 | 2014 | 7312 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18174 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25454 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 29981 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40195 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12054 | 0.010 |
Why?
|
Child | 1 | 2022 | 78594 | 0.010 |
Why?
|
Brain | 1 | 2015 | 26598 | 0.010 |
Why?
|
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_